WebAug 2015 - Sep 20161 year 2 months. San Francisco Bay Area. Project team leader and Clinical lead for Phase 2 Sickle Cell Disease program, with oversight of programs in hyperemic pulmonary disease ... WebSep 9, 2024 · “Versant has made several important investments in the gene editing space, including founding Crispr Therapeutics and Graphite Therapeutics, and we believe that iECURE represents the next wave ...
Jasper Therapeutics and Graphite Bio Announce Collaboration to …
WebApr 12, 2024 · Graphite One Inc. ( OTC:GPHOF – Get Rating) shares dropped 1.6% during mid-day trading on Tuesday . The company traded as low as $1.08 and last traded at $1.10. Approximately 47,991 shares ... WebPandion Therapeutics (acquired by Merck & Co, Kenilworth NJ) 2024 - 20244 years. Watertown, MA. Employee #1. $1.85B exit in 4 years. … first year teacher supplies
Graphite Bio Launches with $45 Million Series A Financing
WebMar 15, 2024 · Graphite Bio has received IND clearance from the U.S. Food & Drug Administration (FDA) to initiate its first Phase 1/2 clinical trial evaluating investigational … WebMar 15, 2024 · Graphite Bio has received IND clearance from the U.S. Food & Drug Administration (FDA) to initiate its first Phase 1/2 clinical trial evaluating investigational candidate GPH101 in sickle cell ... WebMr. Truitt is Chairman of the board at Larimar Therapeutics and serves on the board of Code BioTherapeutics. ... “Versant has made several important investments in the gene editing space, including founding Crispr Therapeutics and Graphite Therapeutics, and we believe that iECURE represents the next wave of innovation in this space,” said ... first year television usa